Mangoceuticals, Inc.
MGRX
$4.91
-$0.37-7.01%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 73.90K | 490.20K | 15.30K | 739.00K | 1.24M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | 13.20K | 14.00K | 14.50K | 18.50K | 21.60K |
| Prepaid Expenses | -- | -- | 60.10K | 61.00K | 84.40K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 16.90K | 13.30K | -- | -- | -- |
| Total Current Assets | 104.10K | 517.60K | 89.80K | 818.50K | 1.34M |
|
|
|||||
| Total Current Assets | 104.10K | 517.60K | 89.80K | 818.50K | 1.34M |
| Net Property, Plant & Equipment | 78.00K | 213.10K | 194.70K | 215.40K | 235.90K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 14.61M | 14.61M | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -102.90K | 16.90K | 16.90K | 16.90K |
| Total Assets | 14.79M | 15.24M | 301.40K | 1.05M | 1.60M |
|
|
|||||
| Total Accounts Payable | 754.00K | 718.70K | 1.05M | 140.80K | 89.10K |
| Total Accrued Expenses | 5.60K | 4.70K | 8.20K | 6.60K | 8.20K |
| Short-term Debt | 187.50K | 187.50K | 87.50K | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 69.30K | 67.40K | 65.60K | 63.70K | 61.90K |
| Total Finance Division Other Current Liabilities | 375.00K | 400.00K | -- | -- | -- |
| Total Other Current Liabilities | 375.00K | 400.00K | -- | -- | -- |
| Total Current Liabilities | 1.39M | 1.38M | 1.21M | 211.10K | 159.20K |
|
|
|||||
| Total Current Liabilities | 1.39M | 1.38M | 1.21M | 211.10K | 159.20K |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 187.50K | 187.50K | 87.50K | -- | -- |
| Capital Leases | 12.20K | 30.10K | 47.70K | 65.00K | 81.50K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 1.40M | 1.41M | 1.26M | 276.00K | 240.70K |
|
|
|||||
| Common Stock & APIC | 31.59M | 30.30M | 12.64M | 12.00M | 10.01M |
| Retained Earnings | -17.99M | -15.99M | -13.60M | -11.23M | -8.66M |
| Treasury Stock & Other | -217.40K | -486.70K | -100.00 | -- | -- |
| Total Common Equity | 13.39M | 13.83M | -958.40K | 774.80K | 1.35M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 100.00 | 100.00 | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 100.00 | 100.00 | -- | -- | -- |
|
|
|||||
| Total Common Equity | 13.39M | 13.83M | -958.40K | 774.80K | 1.35M |
| Total Preferred Equity | 100.00 | 100.00 | -- | -- | -- |
| Total Minority Interest | -800.00 | -400.00 | 0.00 | -- | -- |
| Total Equity | 13.39M | 13.83M | -958.50K | 774.80K | 1.35M |
|
|
|||||
